Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Motorola Solutions Inc (MSI): ValueAct Sells Shares Back to Company; Further Cuts CBRE Group Inc (CBG) Stake

Jeffrey Ubben‘s ValueAct Capital has reported cutting its positions in Motorola Solutions Inc (NYSE:MSI) and CBRE Group Inc (NYSE:CBG), as several new filings with the Securities and Exchange Commission showed. ValueAct has sold some 11.32 million shares of Motorola Solutions in one transaction at a price of $66.26 per unit. Moreover, the fund reported the sale of around 579,900 class A shares of CBRE Group in three deals, at an average price of $32.07 per share. Following the moves, ValueAct holds close to 17.59 million shares of Motorola Solutions and 31.32 million shares of CBRE Group Inc (NYSE:CBG).


ValueAct’s position in Motorola Solutions Inc (NYSE:MSI) is activist by nature and amasses 7.8% of the company’s common stock. The investor has also a representative on the company’s board, Bradley Singer. The fund sold shares to Motorola Solutions under the terms of a stock purchase agreement, the total value of the deal reaching around $750 million, and has been carried out under Motorola’s $12 billion buyback program.

ValueAct has been holding shares of Motorola Solutions Inc (NYSE:MSI) since the first quarter of 2012, but prior to that it held shares of Motorola Corp. Since the fund first disclosed holding shares of Motorola Solutions, its stock appreciated by around 35%, while ValueAct has not made any significant changes to the position. However, ValueAct’s strategy implies long-term investment and owns stocks for several years to gain value.

In addition to ValueAct, William B. Gray’s Orbis Investment Management owns around 11.99 million shares of Motorola Solutions Inc (NYSE:MSI) as of the end of June, followed by David Cohen and Harold Levy Iridian Asset Management with 3.55 million shares. Moreover, the company is also backed by such famous investors as George Soros’ Soros Fund Management, which held 1.84 million shares and Leon Cooperman’s Omega Advisors with 2.94 million shares.

In addition, ValueAct has been selling shares of CBRE Group Inc (NYSE:CBG) over the last couple of weeks. The fund has recently revelead the sale of other 262,731 class A shares of the company in three transactions at an average price of $32.16 per unit. Aside from CBRE and Motorola Solutions Inc (NYSE:MSI), Jeff Ubben has been picking profits from another long-term position, Rockwell Collins, Inc. (NYSE:COL)of which ValueAct disposed of 3.39 million shares a couple of days ago; the fund currently owns an activist stake, which contains 7.80 million shares, equal to 5.8% of the company.

Taking into account how well Mr. Ubben picks worked over the long-term, it is important to follow his bullish moves, and there have been some interesting acquisitions recently. A couple of weeks ago, ValueAct Capital initiated an activist stake in Agrium Inc. (USA) (NYSE:AGU), which contains 8.19 million shares, equal to 5.7% of common stock. Moreover, the fund has been buying shares of Allison Transmission Holdings Inc (NYSE:ALSN) for the last several months. In the last filing, ValueAct reported the acquisition of 275,000 shares, taking the position to 19.13 million shares. ValueAct initiated its buying spree of Allison Transmission Holdings at the beginning of October, by acquiring 550,000 shares, taking the stake to 18.58 million shares, equal to 10.5% of the company. Moreover, recently, Mr. Ubben has been appointed as a director on the board of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and ValueAct has increased its stake to 18.93 million shares, representing 5.6% of the company.

Since following the moves of great investors such as Mr. Ubben is important, because this strategy can provide market-beating investment opportunities to smaller investors, we keep track of all ValueAct’s moves, as well as many other notorious money managers. So, we will keep you in the loop regarding other major steps taken by biggest hedge fund managers.

Disclosure: none

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!